rdca-dap: how the data and analytics platform accelerates rare disease drug development
Published 3 years ago • 46 plays • Length 8:03Download video MP4
Download video MP3
Similar videos
-
48:02
rdca-dap - value of integrated data and analytics in rare disease drug development
-
1:36:06
webinar: rdca-dap and eatris present rare disease drug development
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
1:34:43
eatx rdca-dap - webinar on ‘data sharing and analysis to support rare disease drug development‘
-
4:17
rdca-dap: shortening the timeline for developing new treatments for rare diseases
-
55:49
sharing data with rdca-dap: your questions answered
-
4:33
the drug development process
-
53:31
ai-powered real-world simulations for faster and value-based rare disease drug development
-
2:14:29
rare neurodegenerative disease efforts under the act for als
-
30:09
how to connect software dev and qa ra team
-
56:42
improving data collection for rare epilepsies: case example from the tsc natural history database
-
4:16
rdca-dap platform preview
-
38:32
rdca-dap launch live stream - am part 1
-
35:05
2021 rdca-dap annual workshop: how rdca-dap is working to break down silos
-
12:03
rdca-dap drug development tool prototypes
-
1:25:50
rdca-dap launch live stream - pm part 1
-
4:12
why are high-quality standardized databases so critical for drug development?
-
58:44
shortening the timeline for developing new treatments - how the rdca-dap can help
-
58:49
webinar: how rdca-dap can help inform optimal trial design in progressive rare disease
-
58:09
patient focused drug development - how rdca-dap can help
-
3:27
what does the fda hope to achieve through developing the rare disease cures accelerator?
-
3:44
rare disease challenges in each step of the drug development process